Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medagel is a biotechnology company specializing in the development and commercialization of advanced hydrogel technologies for medical applications. The company's proprietary hydrogel platform is used to create high-water-content dressings that provide a moist environment for wound healing and can serve as a vehicle for controlled drug delivery. Their products are primarily used in wound care, post-operative recovery, and the treatment of various skin conditions. Medagel's technology focuses on biocompatibility and the ability to deliver active ingredients transdermally. The company's portfolio includes specialized products for burns, blisters, and chronic wounds, marketed to both clinical and consumer segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medagel.